Biocon likely to seek full marketing authorisation for Covid-19 drug - Dealers Care

Breaking

BANNER 728X90

Sunday, 25 July 2021

Biocon likely to seek full marketing authorisation for Covid-19 drug

Expects results from phase 4 study of itolizumab by end of this quarter

from Latest News https://ift.tt/3rLHxdf

No comments:

Post a Comment

loading...